【レポートの概要(一部)】
PART 01: Executive summary
• Highlights
PART 02: Scope of the report
• Market overview
• Top-vendor offerings
PART 03: Market research methodology
• Research methodology
• Economic indicators
PART 04: Introduction
• Key market highlights
PART 05: Disease overview
• Understanding the disease
• Pathophysiology
• Diagnosis
• Manifestations of cystic fibrosis
PART 06: Pipeline analysis
PART 07: Market landscape
• Market overview
• Market size and forecast
• Five forces analysis
PART 08: Market segmentation by drug class
• CFTR modulators
• Mucolytics
• PERT
• Anti-infectives
• Bronchodilators
PART 09: Market segmentation by molecule type
• Small molecules
• Biologics
PART 10: Geographical segmentation
• Global cystic fibrosis therapeutics market by geography
• Cystic fibrosis therapeutics market in Americas
• Cystic fibrosis therapeutics market in EMEA
• Cystic fibrosis therapeutics market in APAC
PART 11: Key leading countries
• The US
• The UK
• France
• Canada
• Italy
PART 12: Market drivers
• Special regulatory designations for drugs
• Increased uptake of CFTR modulators
• Improvement in diagnostic technologies
PART 13: Impact of drivers
PART 14: Market challenges
• Discontinuation of drugs from development
• Difficulty in developing drugs due to rarity of disease
PART 15: Impact of drivers and challenges
PART 16: Market trends
• Co-pay and assistance programs by vendors
• Strategic collaborations
• Advances in technology for drug development and delivery
PART 17: Vendor landscape
• Competitive scenario
• Other prominent vendors
PART 18: Key vendor analysis
• Vertex Pharmaceuticals
• F. Hoffmann-La Roche
• AbbVie
• Gilead Sciences
• Novartis
PART 19: Appendix
• List of abbreviations
PART 20: Explore Technavio
[List of Exhibits]
Exhibit 01: Product offerings
Exhibit 02: Key buying criteria for global cystic fibrosis therapeutics market 2015
Exhibit 03: Key customer segments of cystic fibrosis therapeutics market
Exhibit 04: Snapshot of cystic fibrosis
Exhibit 05: Defects caused by CFTR mutation
Exhibit 06: Diagnosis of cystic fibrosis
Exhibit 07: Pipeline portfolio: Global cystic fibrosis therapeutics market
Exhibit 08: Global cystic fibrosis therapeutics market: Market overview 2015
Exhibit 09: Global cystic fibrosis therapeutics market snapshot: Developed and emerging markets 2015
Exhibit 10: Global cystic fibrosis therapeutics market 2015-2020 ($ billions)
Exhibit 11: Opportunity analysis: Global cystic fibrosis therapeutics market
Exhibit 12: Impact of factors affecting the market 2015 and 2020
Exhibit 13: Five forces analysis
Exhibit 14: Global cystic fibrosis therapeutics by drug class 2015
Exhibit 15: Global cystic fibrosis therapeutics market by molecule type 2015
Exhibit 16: Global cystic fibrosis therapeutics market by geography 2015-2020
Exhibit 17: Percentage share of global cystic fibrosis therapeutics market by geography 2015 and 2020
Exhibit 18: Global cystic fibrosis therapeutics market by geography 2015-2020 ($ billions)
Exhibit 19: Global share of cystic fibrosis therapeutics market by geography 2015
Exhibit 20: Global cystic fibrosis therapeutics market by region: Market growth lifecycle analysis 2015
Exhibit 21: Global cystic fibrosis therapeutics market: Country analysis based on revenue and growth rate
Exhibit 22: Opportunity analysis: Cystic fibrosis therapeutics market in Americas
Exhibit 23: Cystic fibrosis therapeutics market in Americas 2015-2020 ($ billions)
Exhibit 24: Opportunity analysis: Cystic fibrosis therapeutics market in EMEA
Exhibit 25: Cystic fibrosis therapeutics market in EMEA 2015-2020 ($ billions)
Exhibit 26: Opportunity analysis: Cystic fibrosis therapeutics market in APAC
Exhibit 27: Cystic fibrosis therapeutics market in APAC 2015-2020 ($ millions)
Exhibit 28: Key leading countries for cystic fibrosis therapeutics market
Exhibit 29: Impact of drivers and challenges on global cystic fibrosis therapeutics market
Exhibit 30: Few drugs with breakthrough therapy designation for cystic fibrosis
Exhibit 31: Drugs with orphan drug designation for cystic fibrosis
Exhibit 32: Impact of drivers
Exhibit 33: Few cystic fibrosis therapeutics discontinued from development
Exhibit 34: Impact of drivers and challenges
Exhibit 35: Global cystic fibrosis therapeutics market: Impact assessment of key trends
Exhibit 36: Few cystic fibrosis therapeutics with patient assistance programs
Exhibit 37: Key vendors ranking 2015
Exhibit 38: Geographical presence of key vendors 2015
Exhibit 39: Competitive scenario of market vendors 2015-2020
Exhibit 40: Vertex Pharmaceuticals: Profile
Exhibit 41: Vertex Pharmaceuticals: Strength analysis
Exhibit 42: Vertex Pharmaceuticals: Growth strategy matrix
Exhibit 43: Vertex Pharmaceuticals: Opportunity assessment
Exhibit 44: Vertex Pharmaceuticals: Revenue of ORKAMBI and Kalydeco 2015 ($ millions)
Exhibit 45: F. Hoffmann-La Roche: Profile
Exhibit 46: F. Hoffmann-La Roche: Strength analysis
Exhibit 47: F. Hoffmann-La Roche: Growth strategy matrix
Exhibit 48: F. Hoffmann-La Roche: Opportunity assessment
Exhibit 49: F. Hoffmann-La Roche: YoY growth and revenue generated from sales of Pulmozyme 2013-2015 ($ millions)
Exhibit 50: AbbVie: Profile
Exhibit 51: AbbVie: Strength analysis
Exhibit 52: AbbVie: Growth strategy matrix
Exhibit 53: AbbVie: Opportunity assessment
Exhibit 54: AbbVie: YoY growth and revenue of Creon 2013-2015 ($ millions)
Exhibit 55: Gilead Sciences: Profile
Exhibit 56: Gilead Sciences: Strength analysis
Exhibit 57: Gilead Sciences: Growth strategy matrix
Exhibit 58: Gilead Sciences: Opportunity assessment
Exhibit 59: Novartis: Profile
Exhibit 60: Novartis: Strength analysis
Exhibit 61: Novartis: Growth strategy matrix
Exhibit 62: Novartis: Opportunity assessment
【レポート販売概要】
■ タイトル:嚢胞性線維症(CF症)治療薬の世界市場2016-2020■ 英文:Global Cystic Fibrosis Therapeutics Market 2016-2020
■ 発行日:2016年10月5日
■ 調査会社:Technavio
■ 商品コード:IRTNTR10588
■ 調査対象地域:グローバル
- 耐火材料のグローバル市場動向(2014-2018)About Refractory Materials Refractory materials are used in the refractory lining of furnaces, kilns, incinerators, and reactors. These These materials have a high melting point (greater than 2768 degrees Fahrenheit). They are subjected to various conditions such as high temperature, abrasion and chemical corrosion, slag attack, and chemical reactions when they are used in refractory linings. Henc …
- ビデオ監視の世界市場:システム種類別(アナログ監視、IP監視、ハイブリッド監視)、コンポーネント別(ハードウェア、ソフトウェア、サービス)、用途別(商業、軍事、防衛、インフラ、住宅、その他)Video surveillance systems can be used for almost any environment. Owing to increase in adoption of advanced surveillance by the government sector, manufacturers have realized the need for optimum IP surveillance systems. There are many advantages that an IP camera CCTV system offers over an analog format. There has been an increase in demand for security applications such as video surveillance to …
- 産業用半導体の世界市場:アナログIC、ディスクリートIC、オプトエレクトロニクス、MCU、センサー、ロジックIC、メモリー、MPUAbout semiconductors The high mobility of semiconductors at room and higher temperatures makes them the best material for use in electronic equipment. Semiconductors are used to fabricate products such as ICs used in circuitry of electronic devices. They are also used to make lasers and LEDs, because the presence of impurities or dopants enables them to emit light of a specific color when a voltag …
- おむつの世界市場:幼児用おむつ、大人用おむつAbout Diaper Market The global baby diaper market was dominated by the disposable diapers segment in 2015, followed by the training diapers, cloth diapers, swim pants, and biodegradable diaper segments. While baby diapers can be used by all babies, adult diapers are generally used by people aged above 55 years who suffer from problems such as incontinence, diarrhea, dementia, and physical disabili …
- 統合失調症(Schizophrenia):企業動向PharmaPoint: Schizophrenia - Current and Future Players Summary GlobalData has released its pharma report, “PharmaPoint: Schizophrenia - Current and Future Players”. The report is a vital source of up-to-date information with in-depth analysis on the companies in the rapidly growing Schizophrenia Market. The report identifies and analyses the key companies shaping and driving the global Schizophre …
- 世界のLCOS(Liquid Crystal on Silicon)市場動向(2012-2016)TechNavio’s analysts forecast the Global Liquid Crystal on Silicon market to grow at a CAGR of 38.13 percent CAGR over the period 2012-2016. One of the key factors contributing to this market growth is the increasing demand in the Automotive sector. The Global Liquid Crystal on Silicon market has also been witnessing a trend of declining average selling prices of liquid crystal on silicon. However …
- 小腸結腸炎(Enterocolitis):世界の治験レビュー(2015年上半期版)Enterocolitis Global Clinical Trials Review, H1, 2015 Summary GlobalData's clinical trial report, “Enterocolitis Global Clinical Trials Review, H1, 2015" provides data on the Enterocolitis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Enterocolitis. It includes an overview of the trial numbers and their recruitment status as per the …
- 凍結保存装置の世界市場2017-2021ABSTRACTAbout Cryopreservation Systems Cryopreservation is the process of preserving living organisms, cells, or tissues by cooling them at very low temperatures to avoid any damage caused by unregulated chemical kinetics. Phenomena that can cause damage to cells during cryopreservation mainly occur during the freezing stage. This includes solution effects, dehydration, extracellular ice formation …
- ホワイトバイオテクノロジーの世界市場分析:製品別(バイオ燃料、バイオマテリアル、生化学、工業用酵素)、用途別(バイオエネルギー、食品・飼料添加物、医薬品原料、パーソナルケア・家庭用品)、セグメント予測The global white biotechnology market is expected to reach USD 487.08 billion by 2024, according to a new report by Grand View Research, Inc. Rising awareness and emphasis for the adoption of greener and environment-friendly technologies in various end-use industries is expected to drive the market over the next eight years. Biofuels accounted for over 35% of the market in terms of revenue on acco …
- Immunotherapy Development Strategies – An Evolving Market with Significant Potential but with Challenging Hurdles to OvercomeAlthough immunotherapy was first recognized over 100 years ago, it has only become an important therapeutic tool in recent decades. The immune system can be harnessed in one of several ways to tackle various diseases such as cancer, infection, auto-immune disease and inflammatory diseases. The complexity of the immune system has led to some intrinsic obstacles with clinical research, particularly …
- 呼吸器保護器具(RPE)の世界市場分析:製品別(空気清浄呼吸器(APR)、無給電式、使い捨てフィルターハーフマスク、ハーフマスク、フルフェイスマスク、電動ファン付き呼吸用保護具(PAPR)、ハーフマスク、フルフェイスマスク、ヘルメット、フード&バイザー、避難用呼吸用保護具、供給空気呼吸器、自給式呼吸器(SCBA)、フルフェイスマスク、航空機用呼吸器)、エンドユーザー別、セグメント予測The global respiratory protective equipment market is expected to reach USD 8.53 billion by 2022, according to a new report by Grand View Research, Inc. Rising awareness towards employee health & safety along with increasing respiratory diseases is anticipated to drive industry growth over the forecast period. Established safety standards by regulatory agencies including Occupational Safety and He …
- 新規用途向けジェスチャ認識の世界市場2016-2020About Gesture Recognition Technology Human-machine interaction has reduced the gap between the two and developed a more natural and intuitive interaction. Humans have come a long way from controlling machines through switches fitted on them to remote controls, and currently, through smartphones. In the future, it will be through natural gestures. Gesture control is by far the most natural form of …
- フェニールケトン尿症(Phenylketonuria):グローバル臨床試験動向(2014年上半期)Phenylketonuria (PKU) Global Clinical Trials Review, H1, 2014 Summary GlobalData's clinical trial report, “Phenylketonuria (PKU) Global Clinical Trials Review, H1, 2014" provides data on the Phenylketonuria (PKU) clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Phenylketonuria (PKU). It includes an overview of the trial numbers and the …
- 子宮内膜症:市場分析及び予測(~2017)OpportunityAnalyzer: Endometriosis - Opportunity Analysis and Forecasts to 2017 Summary Endometriosis is a gynecological disorder affecting women of childbearing age. This inflammatory condition is characterized by the growth of endometrial tissues outside of the uterus, and can cause chronic painful menstruation, painful intercourse, and infertility. For many women, endometriosis-associated pain …
- Liver Fibrosis:グローバル臨床試験レビューH2, 2013Liver Fibrosis Global Clinical Trials Review, H2, 2013 Summary GlobalData's clinical trial report, “Liver Fibrosis Global Clinical Trials Review, H2, 2013" provides data on the Liver Fibrosis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Liver Fibrosis. It includes an overview of the trial numbers and their recruitment status as per …